Breast cancer heterogeneity among patients can be classified into luminal and basal-like immuno histo chemical profiles based on estrogen receptors (ER), progesterone receptors(PR), and human epidermal growth factor receptor (HER2). This evidence concerns the gene PGR and breast carcinoma.